🔎 Trials Near Me

ホーム › 骨髄異形成症候群

米国で参加者を募集している骨髄異形成症候群の臨床試験

米国全土の拠点で、骨髄異形成症候群に関する157件の研究が参加者を募集しています。

最も多くの研究がある都市

州別

最近更新された研究

公式研究テキスト（英語）

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

被験者募集中第1/2相
12歳〜120歳 · 全性別 · 2026/10/02更新 · NCT06303193

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06577441

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

被験者募集中第1相
18歳〜120歳 · 全性別 · 2026/10/02更新 · NCT06904066

Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders

被験者募集中観察研究
1 Day – 99 Years · 全性別 · 2026/10/02更新 · NCT07683104

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06484062

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

被験者募集中第1/2相
4歳〜75歳 · 全性別 · 2026/10/01更新 · NCT03173937

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07285044

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

被験者募集中第1相
12歳〜78歳 · 全性別 · 2026/09/29更新 · NCT03802695

CHIP/CCUS Natural History Protocol

被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/09/28更新 · NCT04102423

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05564390

A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06548230

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

被験者募集中早期第1相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06398457

Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT03661307

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT05320198

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

被験者募集中第2相
4歳〜80歳 · 全性別 · 2026/09/22更新 · NCT01174108

Natural History Study of GATA2 Deficiency and Related Disorders

被験者募集中観察研究健康なボランティア歓迎
2歳〜100歳 · 全性別 · 2026/09/22更新 · NCT01905826

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07422480

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

被験者募集中第1相
1歳以上 · 全性別 · 2026/09/18更新 · NCT03630991

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT04375631

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT04282187

Collection of Tissue Samples for Cancer Research

被験者募集中観察研究
2 Months · 全性別 · 2026/09/16更新 · NCT00900198

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06904482

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT03471260

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT03683433

A Study of BGB-11417 in Participants With Myeloid Malignancies

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT04771130

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。